Office management of uveitis.
D000963:Antimetabolites / Q000627:therapeutic use; D005938:Glucocorticoids / Q000009:adverse effects; D006660:Histoplasmosis / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011480:Protease Inhibitors; D014126:Toxoplasmosis, Ocular / Q000628:therapy; D014392:Tuberculosis, Ocular / Q000628:therapy; D014605:Uveitis / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*
D000963:Antimetabolites; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011480:Protease Inhibitors